During the past decade, LinQ Research, LLC conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LinQ Research, LLC" #1 sponsor was "Pfizer" with 5 trials, followed by "BioNTech SE" with 2 trials sponsored, "Bond Avillion 2 Development LP" with 1 trials sponsored, "Hepion Pharmaceuticals, Inc." with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LinQ Research, LLC" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "LinQ Research, LLC" are "COVID-19" (5 trials), "SARS-CoV-2 Infection" (2 trials), "Asthma" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "LinQ Research, LLC" in a lesser frequency.

Most popular intervention types in "LinQ Research, LLC" are "Drug" (12 trials), "Biological" (5 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "BNT162b2" (2 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "AS MDI" (1 trials). Other intervention names were less common.

The vast majority of trials in "LinQ Research, LLC" are 17 trials for "All" genders.

Currently, there are NaN active trials in "LinQ Research, LLC". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in LinQ Research, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in LinQ Research, LLC, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".